InstructorRoyed Training
TypeOnline Course
Price$390 / 27300 INR.
Buy NowBook Now
Loading
Loading
Brazil pharmaceutical regulatory affairs

Introduction

Feature

Who should attend

Certification

Related Courses

About Brazil RA Program

Drug Registration and Regulation of Brazil

Master Brazil’s Pharma Regulatory Landscape

This specialized online certification course offers in-depth training on the pharmaceutical marketing authorization (MA) process in Brazil, equipping learners with practical knowledge and strategic skills essential for navigating the complex regulatory framework of the Brazilian market.

The course comprehensively covers:

  • The latest ANVISA regulations
  • Detailed steps for Marketing Authorization Application (MAA)
  • Brazil-specific Common Technical Document (CTD) structure and dossier submission guidelines
  • Strategic regulatory planning for pharmaceuticals and biopharmaceuticals

Whether you’re new to Regulatory Affairs or already working in the domain, this course is designed to enhance your competencies and empower you to manage Brazil’s pharmaceutical MAA processes efficiently.

Course Snapshots

  • Course Code: RYD-068
  • Title of the course: Advance Certification in Brazil Pharmaceutical Regulatory Affairs
  • Nature of the course: Online self-paced learning. Hence, the course can be accessed online across anywhere 24×7. The course can be completed at any place, allowing the user to stop and start at their leisure.
  • Access Duration: 1 Month
  • Certification: Certificate will be provided at the end of the successful completion of the course.
  • Eligibility: Graduation in any discipline. Even the final year student can join the course

Through interactive exercises, reflection activities, and a final assessment, learners will apply key concepts in real-world regulatory scenarios. Plus, with flexible 24×7 access, you can learn at your own pace — anytime, anywhere.

Key Features of the Brazil Pharmaceutical Regulatory Affairs Online Certification Course

Interactive and Practical Learning Experience

This online course leverages advanced interactive learning tools to guide participants through a step-by-step understanding of Brazil’s pharmaceutical regulatory environment. From strategic planning to dossier preparation, each module is designed to build hands-on expertise.

Strategic Regulatory Affairs Skill Development

Focused on enhancing regulatory strategic management capabilities, the course enables learners to function effectively as RA professionals within the Brazil pharma market. Real-world simulations and scenario-based challenges ensure applied learning.

Engaging Learning Tools

The course features interactive exercises, reflection-based questions, and expert live chat support — making the learning process dynamic, engaging, and learner-centric.

Comprehensive Regulatory Coverage

  • Detailed understanding of drug registration pathways in Brazil, including the Full Application, Verification, and Abridged pathways.
  • Emphasis on Common Technical Document (CTD) format, dossier compilation, and submission strategies.
  • Insights into strategic decision-making for various product classes — from small molecules to biologics.

Advanced Technical Modules Included

Gain deeper understanding through dedicated sessions on:

  • CMC documentation
  • Stability studies
  • Drug Master File (DMF) and Site Master File (SMF) preparation
  • Good Manufacturing Practices (GMP) modules

Self-Paced with Global Access

Learn at your own pace, anytime and anywhere. The course is fully online and accessible 24×7, allowing maximum flexibility for working professionals.

Downloadable Study Material

All course materials are available for download via the learner dashboard — ideal for offline study and future reference, even after course completion.

This course is ideal for professionals and learners who are looking to gain specialized knowledge and strategic insight into the Brazilian pharmaceutical regulatory landscape, including:

Freshers and Beginners

Those new to the pharmaceutical industry who wish to understand the fundamentals of Brazil’s regulatory environment and market entry requirements.

Drug Regulatory Affairs Professionals

RA executives seeking to deepen their expertise in Brazil-specific regulatory procedures, marketing authorization, and dossier management.

Business Development & Strategic Management Professionals

Professionals involved in international business expansion, product registration, and market strategy who need a clear understanding of regulatory pathways and strategic planning for Brazil.

IPR, Strategic Management and Compliance Experts

Those working in intellectual property, strategic management, legal, or compliance functions looking to align regulatory knowledge with strategic decision-making in the Brazil market.

 

At Royed Training, we have LATAM Regulatory Affairs Online Certification Course to gain the competitive edge to navigate the complex pharmaceutical regulatory landscape of Latin America.

Course coverage: Country-specific regulatory framework (Brazil, Mexico, Argentina, Colombia, Chile, Peru, El Salvador, etc.), dossier preparation and submission (Module 1 and 2 CTD), GMP & site registration, pharmacovigilance regulations, regulatory strategy planning, registration timelines and pathway analysis, lifecycle management, labeling compliance, pricing and reimbursement strategy, and real-world regulatory case studies.

Few of the Other Regulatory Affairs Course 

Why Royed’s Brazil Drug Regulatory Affairs Course is Essential

Master Brazil’s Complex Regulatory Landscape

Brazil, with its rapidly growing pharmaceutical market and unique regulatory system governed by ANVISA, presents both opportunities and challenges for drug registration. Royed’s specialized training offers the clarity and confidence needed to navigate this intricate environment.

Stay Ahead with the Latest ANVISA Guidelines

Brazil’s regulatory guidelines are continuously evolving. This course ensures learners are up-to-date with the most current procedures, CTD requirements, and registration pathways, helping them stay compliant and competitive.

Strategic Edge for Regulatory & Business Professionals

Unlike general RA programs, this course integrates regulatory operations with strategic planning, empowering professionals to make informed decisions in product registration, market entry, and compliance strategies.

Built by Experts, Designed for Practical Use

Developed by industry-leading regulatory professionals, the course focuses on real-world application, including case studies, interactive tools, and simulations tailored specifically to Brazil’s pharmaceutical ecosystem.

Critical for Global Pharma Expansion

For companies and professionals looking to expand into Latin America, Brazil is a key market. This training is a crucial investment in gaining regulatory competence, minimizing approval delays, and ensuring successful product launches.

Section 1Fundamental Sessions
Lecture 1Introduction to Pharmaceutical R&D | Drug Discovery Development Process
Lecture 2Investigational New Drug and Investigational New Drug Application
Lecture 3Understanding on New Drug and New Drug Application
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA) 
Lecture 6Clinical Trials Terminologies 
Lecture 7Clinical Trial Protocol Writing
Lecture 8Ethics in Clinical Research
Lecture 9Informed Consent | Practical Training on preparing ICF | Ready Templates
Lecture 10Review on Drug Discovery and Development 
Lecture 11Introduction to Latam Pharma Market
Lecture 12Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 13Orphan Drug Designation 
Section 2Brazil Marketing Authorization Process
Lecture 14Marketing Authorization Process | Product Types and classes | Submission Pathways | MA Variation | Renewals | Handling online submission process
Lecture 15Chemistry, Manufacturing & Controls 
Lecture 16Fundamental of CMC | Detailed understanding of CMC section writing | Important Points regarding CMC | Drug Product and Drug Substance | Excipient, FP, Analysis and Stability Study Requirements
Lecture 17Introduction to ICH | Members | Guidelines 
Lecture 18ICH Q1 : Stability Guideline | Matrixing | Bracketing
Lecture 19ICH Q2 : Analytical Validation 
Lecture 20ICH Q3 : Impurities
Lecture 21Key Consideration for Drug Master File Preparation and Submission 
Lecture 22Introduction to Common Technical Document (CTD)
Lecture 23CMC Dossier & Compliance Management
Lecture 24Electronic Common Technical Document (ECTD)
Lecture 25Advance Practical Training on Dossier Preparation focusing on drug registration in export countries 
Lecture 26Key Consideration for Drug Master File Preparation and Submission 
Lecture 27Practical Understanding on Drug Master File Preparation and Submission
Lecture 28Site Master File - Detailed Understanding 
Lecture 29Drug Master File - Global Perspective [Across Different Regions]
Lecture 30Importance of effective dossier management
Lecture 31Discussion on 85 common deficiencies in CTD submission dossier
Section 3GMP Management and Plant Inspection Handling
Lecture 32Certification Pharmaceutical Companies / Plants
Lecture 33Premises & Plant Layout Designing
Lecture 34Sanitation and Hygiene
Lecture 35Equipment Modules
Lecture 36Production Modules
Lecture 37Documentation
Lecture 38Product Complaint
Lecture 39Storage Module
Lecture 40Quality Risk Management | ICH Q9 | ISO 14971 | Principle of Risk Management 
Lecture 41Introduction to Certificate of Pharmaceutical Product | Types of CoPP | List of Countries / Regulatory Authorities who requires CoPP | CoPP as a part of generic market expansion planning 
Lecture 42WHO-GMP Certification Scheme 
Lecture 43Template of Certificate of Pharmaceutical product | Key observations and points to note while working on CoPP
Lecture 44WHO Prequalification Status : Significance | Strategic Importance | Submission Process | WHO PQ Documentation | Case study on WHO PQ submission management
Lecture 45WHO EML Vs. WHO PQ | Significance | Importance in Market Access and Regulatory point of view
Section 4Stability Study Requirements
Lecture 46Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 47Climatic Zone and Stability Study Conditions as per ICH Guidelines 
Lecture 48Stability Zone Finder
Lecture 49Stability Studies Case Discussions
Lecture 50Case Study: Managing Stability Study for Zone IV countries
Lecture 51Accelerated and intermediate testing conditions
Lecture 52Long Term Stability Testing Requirements
Lecture 53Testing Frequency
Lecture 54Bracketing
Lecture 55Matrixing
Section 5Request for Course Certificate